Exit watch, week of Nov. 23, 2009

Google continues buying spree, adds Gizmo5 to lineup


has acquired Gizmo5, a San Diego-based provider of calling software for mobile phones and computers. No financial terms were disclosed. Gizmo5 had raised about $6 million in VC funding from Dawntreader Ventures and an undisclosed investor.

MySpace buys Imeem


has agreed to buy most of the assets of Imeem, a San Francisco-based music streaming company, for $1M, as first reported last week by TechCrunch. Imeem had raised more than $12 million in funding from Morgenthaler Ventures, Sequoia Capital and DAG Ventures.

Thomson Reuters scoops up Sabrix

PE Week

publisher Thomson Reuters (NYSE: TRI) has agreed to acquire Sabrix Inc., a San Ramon, Calif.-based provider of transaction tax management software. No financial terms were disclosed. Sabrix has raised about $40 million in VC funding since 2000 from Trinity Ventures, Mohr Davidow Ventures, GKM Ventures and VSP Capital.

Facet buys assets of defunct Archus

Facet Solutions Inc., a Hopkinton, Mass.-based developer of surgical devices for the treatment of degenerative spinal disorders, has acquired the assets of Archus Orthopedics, a Redmond, Wash.-based company that closed its doors three months ago. Archus had raised about $64 million from InterWest Partners, J&J Development Corp., Polaris Venture Partners and MPM Capital. Facet Solutions has raised more than $20 million from De Novo Ventures, FirstMark Capital and Spray Venture Partners.

Initiate acquires Accenx

Initiate Systems Inc., a Chicago-based provider of master data management solutions for the exchange of health information, has acquired Accenx, an Irvine, Calif.-based provider of interoperability solutions for electronic health care records. No financial terms were disclosed. Accenx raised $3 million in Series A funding led by National Healthcare Services. Initiate Systems is also venture-backed, having raised more than $67 million in VC funding from Apex Venture Partners, First Analysis Group, Sigma Partners, BlueCross BlueShield Venture Partners and Paladin Capital Group.

Bioniche Pharma buys injectable drugs from Xanodyne

Bioniche Pharma

, an injectable drugmaker owned by Roundtable Healthcare Partners, has acquired the injectable drugs Duraclon (clonidine hydrochloride injection) and Methadone Hydrochloride Injection USP from Xanodyne Pharmaceuticals Inc. No financial terms were disclosed. Xanodyne, which makes various pharmaceutical products, particularly in women’s health, urology and pain management, has raised more than $230 million in VC funding from AIG Investments, Aisling Capital, Blue Chip Venture Co., Essex Woodlands Health Ventures, HealthCare Ventures, MPM Capital and Union Springs.